Colin McHugh, the Chief Accounting Officer of Accolade, Inc. (NASDAQ:ACCD), recently reported a sale of company stock. On November 4, McHugh sold 448 shares of Accolade common stock at a price of $3.149 per share, amounting to a total transaction value of $1,410.
This transaction was executed to cover tax withholding obligations associated with the vesting and settlement of restricted stock units (RSUs). It is noted that this sale was not a discretionary transaction by McHugh, but rather a mandatory sell to cover taxes.
Following these transactions, McHugh's direct ownership in Accolade stands at 55,528 shares.
In other recent news, Accolade Inc (NASDAQ:ACCD). has been making significant strides in its financial performance, surpassing revenue expectations with a total of $106.4 million in the second quarter of 2025. The company also exceeded its adjusted EBITDA guidance and maintained a substantial cash position of over $234 million. However, several analyst firms including Wells Fargo (NYSE:WFC), Canaccord Genuity, and BofA Securities have revised their price targets for Accolade, reflecting concerns over the timing of deal closures and their impact on the company's anticipated growth.
Wells Fargo, for instance, revised the price target downwards to $6.00, citing concerns over the timing of deal closures. Despite these challenges, the firm suggested that Accolade's revenue targets are still within reach if it achieves moderate growth in Annual Contract Value (ACV). Similarly, Stephens has revised its price target for Accolade to $8.00, while maintaining an Overweight rating, reflecting a 12% revenue growth for the company in fiscal years 2025 and 2026.
Meanwhile, Canaccord Genuity adjusted its price target on Accolade's shares to $7.00, maintaining a Buy rating despite the company's third-quarter guidance falling below estimates. The firm expressed confidence in Accolade's ability to meet performance guarantees and secure new business. Truist Securities also reduced its price target for Accolade to $7.50, while maintaining a Buy rating on the company's stock.
Lastly, BofA Securities revised its price target for Accolade to $5.75, sustaining a Buy rating. The firm remains positive about Accolade's long-term prospects, suggesting that the current market valuation does not fully capture the company's potential. These recent developments reflect the ongoing financial adjustments and strategic direction of Accolade Inc.
InvestingPro Insights
In light of Colin McHugh's recent stock sale, it's worth examining Accolade's current financial position and market performance. According to InvestingPro data, Accolade's market capitalization stands at $256.91 million, reflecting the company's current valuation in the market.
The company's revenue for the last twelve months as of Q2 2025 was $441.03 million, with a revenue growth of 16.04% over the same period. This growth suggests that Accolade is expanding its business operations, despite the recent stock sale by its Chief Accounting Officer.
However, investors should note that Accolade is currently trading near its 52-week low, with the stock price experiencing significant volatility. InvestingPro Tips indicate that the stock has taken a substantial hit over the last six months, with a price total return of -58.22% in that period.
It's also worth noting that Accolade operates with a moderate level of debt, and its liquid assets exceed short-term obligations. This financial structure provides some stability amidst the challenging market conditions.
For investors seeking a more comprehensive analysis, InvestingPro offers 10 additional tips for Accolade, providing a deeper insight into the company's financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.